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Respiratory complexCardiolipin is a mitochondrion-speciﬁc phospholipid that stabilizes the assembly of respiratory chain complexes,
favoring full-yield operation. It alsomediates key steps in apoptosis. In Barth syndrome, an X chromosome-linked
cardiomyopathy caused by tafazzin mutations, cardiolipins display acyl chain modiﬁcations and are present at
abnormally low concentrations, whereas monolysocardiolipin accumulates. Using immortalized lymphoblasts
fromBarth syndromepatients, we showed that the production of abnormal cardiolipin led tomitochondrial alter-
ations. Indeed, the lack of normal cardiolipin led to changes in electron transport chain stability, resulting in
cellular defects. We found a destabilization of the supercomplex (respirasome) I + III2 + IVn but also decreased
amounts of individual complexes I and IV and supercomplexes I + III and III + IV. No changes were observed in
the amounts of individual complex III and complex II. We also found decreased levels of complex V. This complex
is not part of the supercomplex suggesting that cardiolipin is required not only for the association/stabilization of
the complexes into supercomplexes but also for the modulation of the amount of individual respiratory chain
complexes. However, these alterationswere compensated by an increase inmitochondrialmass, as demonstrated
by electron microscopy and measurements of citrate synthase activity. We suggest that this compensatory
increase in mitochondrial content prevents a decrease in mitochondrial respiration and ATP synthesis in the
cells. We also show, by extensive ﬂow cytometry analysis, that the type II apoptosis pathway was blocked at
the mitochondrial level and that the mitochondria of patients with Barth syndrome cannot bind active
caspase-8. Signal transduction is thus blocked before anymitochondrial event can occur. Remarkably, basal levels
of superoxide anion productionwere slightly higher in patients' cells than in control cells as previously evidenced
via an increasedprotein carbonylation in the taz1Δmutant in the yeast. Thismay be deleterious to cells in the long
term. The consequences of mitochondrial dysfunction and alterations to apoptosis signal transduction are consid-
ered in light of the potential for the development of future treatments.
© 2013 Elsevier B.V. All rights reserved., Pharmacologie et Signalisation
e des Saints-Pères, 45 Rue des
6 20 73; fax:+33 1 42 86 38 68.
l rights reserved.1. Introduction
Barth syndrome is a chromosome X-linked cardioskeletal myopathy
and neutropenia (MIM 302060, BTHS). The disease is often fatal in in-
fancy and early childhood, due to heart failure and bacterial infections
[1,2]. Descriptions of this syndrome have been updated in review arti-
cles by Barth et al. [2] and Schlame and Ren [3], which deﬁned Barth
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phospholipid metabolism. Bione et al. [4] identiﬁed the gene respon-
sible, the tafazzin (TAZ) gene, and mapped this gene to region q28 on
the X chromosome. Phospholipid analyses of ﬁbroblasts from patients
and yeast taz1 mutant cells showed cardiolipin levels to be low and re-
vealed changes in acyl chain composition [5–7]. The TAZ gene modiﬁed
in Barth syndrome seems to encode a transacylase essential for the termi-
nal maturation of cardiolipin [7,8].
Cardiolipin [CL or bis-(1,2-diacyl-sn-glycero-3-phospho)-1′,3′-sn-
glycerol] is a key mitochondrial membrane phospholipid [9] con-
sisting of two glycerol-linked phosphatidylmoieties. The four acyl chains
are usually mono- and di-unsaturated fatty acids in higher animals.
Cardiolipin remodeling, by deacylation and successive reacylations, con-
trols the ﬁnal, speciﬁc acyl composition of the molecule. In mammals,
CL is found speciﬁcally in the mitochondrial inner membrane, but tends
to be concentrated at the mitochondrial contact sites [10] connecting
the inner and outer membranes.
CL is associated with and modulates the activity of a number of
keymitochondrial innermembrane enzymes involved in the respira-
tory chain (RC), including cytochrome c oxidase, carnitine palmitoyl-
transferase, creatine phosphokinase, the pyruvate translocator, mono-,
di-, and tricarboxylate carriers, glycerol-3-phosphate dehydrogenase,
the phosphate transporter, ATP/ADP translocase and ATP synthase
[9,11]. CL may be seen as a sort of “glue” holding the mitochondrial
respiratory chain together [12]. It is absolutely required for the activity
of some of these respiratory enzymes and its interactionwithmitochon-
drial proteins is speciﬁc, as enzyme activity is not fully reconstituted if it
is replaced with other phospholipids [13]. Thus, as CL may regulate ATP
generation in cells, the maintenance of appropriate amounts of CL in the
mitochondria is essential for correctmammalian cell function. However,
CL also plays a key role in many other cellular processes, including apo-
ptosis [14,15]. There are currently several lines of evidence supporting
the notion thatmitochondria are autophagic substrates capable of shap-
ing autophagic responses in several ways [16–18]. Recently, and of
greater relevance to our work the physical state of the tafazzin lipid sub-
strate (i.e., CL) has been shown to determine the transacylation speciﬁc-
ity for tafazzin [19].
For death receptor-mediated apoptosis, activation of the mito-
chondrial pathway is required for apoptosis induction in “type II”
cells, but not in “type I” cells. In type I cells, activation of the extrinsic
pathway is sufﬁcient to induce apoptosis. We are concerned here
with the events leading to cell death in type II cells, i.e., the signals
leading from death receptor stimulation to permeabilization of the
outer mitochondrial membrane. Caspase-8 and Bid are the known
procurers of the death signal in this part of the apoptotic pathway
[20]. We previously showed that the mitochondrial surface becomes
enriched in caspase-8 during type II extrinsic apoptosis, and that
blocking the association of caspase-8 with the mitochondria inhibits
p43–p10 formation, thereby preventing BID cleavage and blocking apo-
ptosis [15]. The precisemechanisms for the insertion of active caspase-8
into the mitochondrial membrane remain unclear, although it has re-
cently been shown that caspase-8 and Bid form a supramolecular com-
plex on the mitochondrial membrane surface [15,21].
In the present study, we focused on the apparent compensation of
abnormalities ofmitochondrialmetabolism in Barth syndrome lympho-
blastoid cells (BTHS) [22]. No OXPHOS defect was observed at the cellu-
lar level. Despite decreases in the assembly of respiratory chain (RC)
complexes and supercomplexes and an altered respiration associated
with slight uncoupling observed in mitochondrial isolated and puriﬁed
from such cells. These events were associatedwith slightly higher levels
of superoxide anion production in patient derived lymphoblasts, which
might be deleterious in the long term. We suggest that, in these cells, a
compensatory increase in the number of mitochondria prevents the
loss of mitochondrial respiration and ATP synthesis. We demonstrate
that extrinsic apoptotic signaling in BTHS lymphoblasts is blocked at
the mitochondria, because active caspase-8 could not interact withmitochondria containing immatureCL, norwith the remaining cardiolipin
regardless of acyl chain composition nor with the monolysocardiolipins,
which are present in very high amounts. The consequences of mitochon-
drial dysfunction and changes in apoptosis signal transduction are
discussed in the light of possible future treatments.
2. Materials and methods
2.1. Cell culture and transfection
The lymphoblastoid cell lines were generated from two unrelated
Barth syndrome patients (BTHS; DB105.2 and DB105.3, mutant cells)
and two different controls (DB037, DB015.2, wild-type cells). They
were a gift fromR. Kelley (JohnsHopkinsUniversity School ofMedicine,
Baltimore, MD) and have been described elsewhere [23]. DB105.2 and
DB105.3 have single point mutations in the tafazzin gene, resulting in
substitutions (G197E and I209D, respectively) that inactivate the pro-
tein. These cells were immortalized ex vivo by Epstein–Barr virus infec-
tion. They were cultured in RPMI 1640 GlutaMAX I medium (GIBCO)
supplemented with 10% fetal calf serum (FCS, Harlan), MEM vitamins,
0.5 mM sodium pyruvate, 10 mM HEPES and penicillin (50 IU/ml)
plus streptomycin (50 μg/ml) (all from GIBCO). Other lymphoblast
cell lines from Barth syndrome patients and control subjects were
obtained from the Barth syndrome registry.
2.2. CL and MLCL analysis
Lipid analysis was performed as previously described [24]. Cells were
sonicated for 20 s in PBS and phospholipids were extracted from an
amount of homogenate equivalent to 1 mg of protein, as follows. We
added 3 ml of 1:1 chloroform–methanol (v/v), followed by the internal
standards (0.4 nmol tetramyristoyl-CL and 0.16 nmol dimyristoyl-
phosphatidylglycerol (Avanti Polar Lipids)). Thismixturewas shaken vig-
orously and placed on ice for 15 min, after which it was centrifuged at
1000 ×g for 10 min. The supernatant was transferred to new tubes, and
the protein pellet was re-extracted with 3 ml of 2:1 chloroform-
methanol (v/v). The combined organic layers were evaporated under
nitrogen at 45 °C. The residue was dissolved in 150 μl chloroform/
methanol/water (50:45:5 v/v/v) supplemented with 0.01% NH4OH,
and 10 μl of the resulting solutionwas injected into theHPLCMS system
(ThermoElectronCorporation). The column temperaturewasmaintained
at 25 °C. The lipid extract was injected onto a 2.1 × 250 mm silica
column, with a 5 μm particle diameter (Merck). The phospholipids
were separated from interfering compounds by a linear gradient of solu-
tion B (chloroform–methanol, 97:3, v/v) and solution A (methanol–
water, 85:15, v/v). Solutions A and B contained 0.1 ml and 0.01 ml of
25% (v/v) aqueous ammonia per liter of eluent, respectively. The gradient
(0.3 ml/min) was as follows: 0–10 min: 20% A/80% B to 100% A;
10–12 min, 100% A; 12–12.1 min: 100% A to 0% A; and 12.1–17 min,
equilibration with 0% A. All gradient steps were linear, and the total anal-
ysis time, including equilibration, was 17 min. A splitter was inserted be-
tween the HPLC column and the mass spectrometer, and eluent was
introduced into themass spectrometer at a rate of 75 μl/min. A TSQQuan-
tum AMwas used in the negative electrospray ionizationmode. Nitrogen
was used as the nebulizing gas. The source collision-induced dissociation
collision energy was set at 10 V, the spray voltage used was 3600 V and
the capillary temperature was 300 °C. Mass spectra of CL and MLCL mo-
lecular species were obtained by continuous scanning from m/z 400 to
m/z 1000, with a scan time of 2 s. The spectra of CL and MLCL species
were acquired at their retention times in the HPLC elution proﬁle. The
CL internal standard was set at 100% in each spectrum.
2.3. Induction and assessment of cell death
Cells were treatedwith the optimal concentration (0.5 μg/ml) of anti-
Fas antibody (clone CH11, Beckton Coulter). Mitochondrial membrane
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incubating cells for 15 min at 37 °C (5 × 105/ml) with 2.5 nM tetra-
methylrhodaminemethylester [TMRM,Molecular Probes, 1 mMstock so-
lution in ethanol] for mitochondrial membrane potential determination
or 1 mM hydroethidine (HE; Molecular Probes; 500 mM stock solution)
for superoxide detection. Cells were gated on forward (FSC) and side
(SSC) scatter to exclude debris. Fluorescence was elicited with an argon
laser (excitation wavelength 488 nm) and recorded with a bandpass of
585 ± 20 nm (for TMRM and HE), and a red laser (635 nm) was used
for TO-PRO-3 ﬂuorescence for the simultaneousmonitoring of cell viabil-
ity (recorded with a 661 ± 16 nm bandpass). We analyzed at least
5 × 103 events with CellquestTM software (Becton-Dickinson), on a
FACSCalibur cytometer. Intracellular K+ concentration was measured by
loading cells for 15 to 30 min with 2.5 μM cell-permeant benzofuran
isophthalate acetoxymethyl ester (PBFI-AM; 500 μM stock solution in
dimethylformamide). PBFI ﬂuorescence was excited at 360 nm and
evaluated at 485 ± 20 nm. The level of phosphatidylserine exposure on
the outer plasma membrane was determined by staining cells with
1 mg/ml annexin V-FITC for 10 min at 4 °C (Beckman Coulter, Inc.). The
pH within single cells was monitored with the ﬂuorescent pH indicator
5-(and-6-)-carboxy-seminaphthorhodaﬂuor-1 acetoxymethyl ester ace-
tate (SNARF-1/AM) [25], which has an emission spectrum including
two pH-sensitive bands: one corresponding to the protonated form
(590 nm) and the other corresponding to the non protonated form
(635 nm). Its pK is about 7.4, so pH changes in the 6.3 to 8.6 range can
be determined by measuring the ratio of ﬂuorescence at 635 nm to
that at 590 nm. Cells were incubated in the culture medium for
20 min at 37 °C, under an atmosphere containing 5% CO2, with 10 μM
SNARF-1/AM (1 mM stock solution in DMSO), loaded with probe,
washed and suspended in culture medium containing 25 mM Hepes
(pH 7.4) for ﬂow cytometry. An in vivo calibration curve of R versus
intracellular pH was prepared as described by Thomas et al. [26].
Caspase activities were monitored with caspase-3 and caspase-8 detec-
tion kits (Calbiochem), according to the manufacturer's instructions.
Brieﬂy, cells were harvested and incubated for 30 min at 37 °C in the
presence of a cell-permeant substrate: Red-DEVD-fmk (caspase-3) or
Red-LETD-fmk (caspase-8). Cells were washed twice and analyzed by
ﬂow cytometry. Cells were also selected on the basis of viability, as
estimated by double-staining with TO-PRO-3 (1 μg/ml; wit stock solu-
tion at 1 mg/ml). The level of phosphatidylserine exposure on the
outer plasma membrane was measured by staining cells with 1 μg/ml
annexin V-FITC for 10 min at 4 °C (Immunotech).
2.4. Electroloading of tBid
Cells were ﬁrst resuspended at a density of up to 107/ml in an appro-
priate permeabilization buffer (PB; 10 mM phosphate buffer, 250 mM
sucrose, 1 mMMgCl2, pH 7.4) after centrifugation for 10 min at 100 ×g;
100 ml of cell suspension (106 cells) was placed between two ﬂat stain-
less steel electrodes in parallel at the bottom of a Petri dish and voltage
pulses were applied. The interelectrode distance was 0.5 cm. Electro-
pulsation was carried out with a CNRS electropulsator (Jouan, France),
which delivered square-wave pulses with independently adjustable elec-
tric pulse parameters (voltage, duration, number and frequency). Electric
pulse parameters were monitored with a 15 MHz oscilloscope (Enertec,
France). Cell electropermeabilization was performed at room tempera-
ture. Within 2 s of this process, fetal calf serum (Harlan) was added to
the cell suspension at a ﬁnal concentration of 20% (vol/vol). The cell
suspension was then incubated for 10 min at 37 °C in an incubator
containing 5% CO2/95% air. Unless otherwise indicated, we then added
2 ml of complete culture medium to the cell suspension and incubated
the cells at 37 °C in an incubator containing 5% CO2/95% air until use
[27]. tBid-electroloading efﬁciency was assessed immediately after
electroloading, by immunoﬂuorescence labeling. Control and electro-
loaded cells were suspended in 1 mM EDTA-containing phosphate-
buffered saline (PBS), permeabilized with 0.2% Triton X-100 and ﬁxed in4% paraformaldehyde (PFA). Cells were then incubated with an anti-
mouse Bid antibody (Santa Cruz), which was detected with an FITC-
conjugated secondary antibody. Cell labeling was quantiﬁed in a FACS-
Calibur 4C cytometer (FL-1 channel).2.5. NAD(P)H and NADH determination
NAD(P)H ﬂuorescence was elicited with a multiline ultraviolet
light set at 400 mW on a FACS Vantage. Changes in the autoﬂuores-
cence of normal and apoptotic cells were recorded as previously de-
scribed by Gendron et al. [28]. The light emitted was collected with
a 424 ± 40 nm bandpass for NAD(P)H ﬂuorescence. The NADH con-
tent of the cell was also determined with the NADH/NAD+ or the
NAD(P)H/NAD(P)+ Assay Kit (Cell Technology, Inc., Mountain View,
CA, USA).2.6. Transmission electron microscopy
Cell pellets were ﬁxed by incubation with 2.5% glutaraldehyde in
0.1 Mcacodylate buffer, pH 7.4 for at least 30 min at 4 μC. Theﬁxed spec-
imens were thoroughly washed in 0.1 M cacodylate buffer and then
postﬁxed by incubation in 1% osmium tetroxide in the same buffer for
1 h at room temperature, stained en bloc with 2% uranyl acetate in dis-
tilled water for 15 min, dehydrated in a graded series of acetonitrile con-
centrations, and embedded in Epon resin. Ultrathin sections (80–100 nm
thick) mounted on 150-mesh grids were stained with 2% uranyl acetate
solution and Reynolds lead citrate.2.7. Respiratory analysis for isolated mitochondria
The lymphoblastoidmitochondriawere isolated andpuriﬁed as previ-
ously described [29]. Lymphoblastoid cells (2 × 108 cells, about 11 ±
3 mg of protein) washed three times with medium A (100 mM sucrose,
1 mM EGTA, 20 mM MOPS (pH 7.4), 1 g/l BSA), were resuspended in
1 ml of medium B (medium A plus 10 mM triethanolamine, 5% Percoll,
0.1 mg/ml digitonin). After 3 min of incubation at 4 °C, the cells were
disrupted with 7 strokes of a motor-driven (500 rpm) tightly ﬁtting
glass–Teﬂon pestle. The homogenate was centrifuged twice at 2500 ×g
for 5 min and the resulting supernatant was further centrifuged at
10,000 ×g for 5 min. The mitochondrial pellet (about 1.4 ± 2 mg of
protein) was resuspended in medium C (300 mM sucrose, 1 mM EGTA,
20 mM MOPS (pH 7.4), 1 g/l BSA, 1 mM PMSF). Oxygen uptake was
measured using 100 μg of mitochondrial protein and calculated per mg
of mitochondrial protein which was measured in medium D (300 mM
mannitol, 10 mM KH2PO2 (pH 7.2), 10 mM KCl, 5 mM MgCl2 and 1 g/l
BSA) with a Clark oxygen electrode, in a 300 μl cell, with magnetic stir-
ring, in which the temperature was kept at 37 °C by a thermostat. We
used 1 mM succinate + 5 μM rotenone or 1 mM ascorbate + 500 μM
TMPD as respiratory substrates. We added 70 μM ADP for the measure-
ment of control respiration (CR). We added 10 μM FCCP for full
uncoupling of respiration.2.8. Respiratory chain analysis in whole cells
ATP synthesis wasmeasured as described by Vives-Bauza et al. [30],
with 2.0 × 106 cells, 0.04 mg/ml digitonin and pyruvate and malate as
substrates (both used at a concentration of 1 mM). Oxygen consump-
tion wasmeasured in intact cells, with 1 mMpyruvate as the substrate,
in the presence or absence of the uncoupler carbonyl cyanide
p-triﬂuoromethoxyphenylhydrazone (FCCP, 1 μM), in an Oxygraph
chamber equipped with a Clark-type electrode (Hansatech), at 37 °C,
as described by D'Aurelio et al. [31]. Citrate synthase activity was mea-
sured in total cell lysates, as described by Trounce et al. [32].
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Adenine nucleotides were separated by HPLC on a C18 column
(Polaris 5C18-A, S250*4.6 Repl, Varian, France). The injection volume
was 30 μl. The ﬂow rate was 1 ml/min, and the cartridge was kept at
30 °C in a column oven. The mobile phase was 28 mM pyrophosphate
buffer, pH 5.75. These compoundsweredetectedona spectrophotometer
at a wavelength of 254 nm (L4200 UV Detector, Merck, USA). The reten-
tion times of ATP, ADP and AMPwere 3, 5 and 9 min, respectively. Chro-
matograms were integrated with STAR software v.5 (Varian, France).
2.10. OPA-1 determination
For the assessment of OPA-1 oligomers, mitochondria were isolated
as previously described [33] from DB037 and DB105-3 cells with and
without incubation with 0.5 mg/ml anti-Fas antibody for 24 h. Mito-
chondria were incubated for 30 min at 37 °C with 10 mM EDC (Pierce)
in PBS, and analyzed by SDS-PAGE (4%–12% bis-Tris acrylamide,
Invitrogen), as described by Landes et al. [34]. Immunodetection was
carried out with mouse antibodies against Hsp60 (LK2, Sigma) or cyto-
chrome c (BD Biosciences) and rabbit antibodies against OPA-1.
2.11. Blue native-PAGE and SDS-PAGE
RC complex assembly was studied by BN-PAGE, as previously
described [35]. Brieﬂy, mitochondrial fractions obtained by treating
the cells with 0.05–0.1% digitonin for 10 min were solubilized with
0.3–0.6% n-dodecyl β-D-maltoside (lauryl maltoside, LM) or 0.12–
0.16% digitonin, for the identiﬁcation of individual RC complexes
and supercomplexes, respectively. For the immunodetection of protein
complexes, we used monoclonal antibodies (Invitrogen) against the
following subunits: 39 kDa subunit of complex I, 70 kDa subunit of
complex II, core 2 of complex III, subunit I of complex IV and subunit
β of complex V.
For SDS-PAGE studies, proteins from cell lysates resuspended in
Laemmli sample buffer (BIO-Rad) were separated by SDS-PAGE, blotted
and labeled with antibodies against the heat shock protein 60 (HSP60),
(Stressgen), Mn-superoxide dismutase (MnSOD, Stressgen), subunit I of
complex IV (COXI, Invitrogen), VDAC (Invitrogen), the 30 kDa of com-
plex I (Invitrogen), and TIM23 (BD Biosciences). After incubation with
the appropriate primary antibodies, all the blots were incubated with
secondary antibodies conjugated to horseradish peroxidase (Jackson
ImmunoResearch Laboratories, Inc.), for ﬁnal detection with a Signal
West Pico Chemiluminescent substrate (Thermo Scientiﬁc). Mitochon-
drial proteins were quantiﬁed by densitometric analyses of digitized
Western blot bands, with Scion2 image software, and the results
obtained are expressed as a percentage of WT.
2.12. Statistical analysis
For all assays, the values presented are the means of at least three
independent measurements, unless otherwise speciﬁed. The statistical
signiﬁcance of differences between the WT and the mutant cells was
estimated by unpaired two-tailed Student's t tests, with an asterisk
indicating that p b 0.05.
3. Results
3.1. Electron microscopy of mitochondria in control and BTHS
lymphocytes
As cardiolipin is speciﬁcally located in themitochondrial innermem-
brane and more speciﬁcally at the contact sites between the two mem-
branes, we investigated the effects of CL deﬁciency on the structural
organization of lymphoblast mitochondria. In normal lymphoblasts, mi-
tochondria were located essentially at two positions within the cell:close to the plasma membrane and in the vicinity of the nuclear invagi-
nations typically present in lymphoblasts (Fig. 1A). They contained
groups of parallel cristae, which often extended across the entire body
of the organelle (Fig. 1B and C). In BTHS lymphoblasts, there seemed
to be more mitochondria (Fig. 1D), some of which appeared swollen
and larger than those of control cells. BTHS mitochondria had a distinc-
tive appearance, with major morphological changes and a markedly
lower surface area of cristae. The cristae were no longer organized in
parallel, appearing instead as round structures disconnected from the
peripheral membrane (Fig. 1E and F). In some cases, they had a
honeycomb-like structure (Fig. 1F square a) or adopted a lamellar,
wrapped, curved form (Fig. 1F square b). Moreover, the mitochondrial
membranes often enclosed electron-translucent areas devoid of cristae
(Fig. 1E and F). Amorphometric analysis of the electronmicrographs con-
ﬁrmed that the average mitochondrial cross-section was larger in cells
from patients than in control cells, and that the mitochondrial surface
density was greater in cells from patients than in control cells (Table 1).
3.2. Analysis of CL and MLCL contents
A mass spectrometry comparison of control and BTHS lymphoblasts
(Fig. 2A) showed that BTHS cells contained less mature cardiolipin (CL)
and substantially more monolysocardiolipin (MLCL). Moreover, the acyl
chains of the different CL species in Barth syndrome-derived cells were
less unsaturated, as determined by mass spectrometry analysis, which
showed a shift to higher m/z values within each cluster of CLs (Fig. 2B).
The accumulating MLCL contained particularly large amounts of C18:1
and C16:0 acyl chains. These changes resulted in a complete reorganiza-
tion of the fatty acid proﬁle of CL in BTHS lymphoblasts. They also con-
ﬁrm that DB105.2 and DB105.3 cells presenting a single amino-acid
substitution (G197E and I209D, respectively), display a deﬁciency of
cardiolipin associated with the accumulation of substantial amounts of
MLCL.
3.3. Respiratory activity of the isolated mitochondria
Polarographic studieswere carried out tomeasure succinate (Fig. 3A)
and ascorbate/TMPD (Fig. 3B) respiration levels in control and patient-
derived lymphoblastoid mitochondria. Control mitochondria oxidized
succinate (+ rotenone) at a rate of about 60 nmol O2 min−1 mg−1
protein, with a control respiration (RC) of about 2.2 after the addition
of ADP, whereas mitochondria from patients had a low oxidation rate
(26 nmol O2 min−1 mg−1 protein) and a lower RC, suggesting lower
levels of coupled electron transport activity (Fig. 3A). Similar results
were obtained for the oxidation of ascorbate + TMPD (Fig. 3B), demon-
strating lower levels of respiration inmitochondria from patient-derived
cells than in controlmitochondria, associatedwithmodiﬁed coupling be-
tween electron transport and phosphorylation. Curiously, the uncoupled
respiratory capacity measured with both substrates was the same in the
mitochondria from both patients and normal individuals.
3.4. Respiratory chain assembly in BTHS and control lymphoblasts
CL is known to be a critical component of the inner mitochondrial
membrane, responsible for stabilizing the assembly of inner mem-
brane protein complexes. We analyzed the assembly of RC complexes
in BTHS and control lymphoblasts, by blue native polyacrylamide gel
electrophoresis (BN-PAGE). The optimal conditions for mitochondrial
complex isolation and solubilization were determined by titration
with various amounts of digitonin (DG) and lauryl maltoside (LM),
respectively (Fig. 4A). Individual complexes I, III and V were best
resolved with 0.05% DG and 0.6% LM, whereas individual complex IV
was best resolved with 0.1% DG and 0.6% LM. In these conditions, mu-
tant cells displayed lower levels of assembled complexes I, IV (Fig. 4A
panel 1 and table below), and V (Fig. 4A panel 2 and table below)
than controls. In the presence of 0.3% LM, a partial I + III supercomplex
1 μm
1 μm 0.25 μm
A
D
a
b
*
*
0.25 μm
0.25 μm
0.25 μm
B
C
E
F
Fig. 1. Electronmicrographs ofmitochondria from lymphoblasts from controls and BTHS patients. (A) Control lymphoblasts (DB037). (B) and (C) Structure ofmitochondria from control
lymphoblasts (DB037). (D) Lymphoblasts from a patient (DB105-3). (E) and (F) Structure of mitochondria from the lymphoblasts of a patient (DB105-3). * Electron-translucent area
surrounded by the outer mitochondrial membrane (or a membrane derived from it).
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supercomplex in control cells was incompletely resolved, but nonethe-
less better resolved into its individual complexes. Supercomplex
III + IV levels were lower in BTHS cells than in control cells. No differ-
ence between mutant and WT cells was observed for the assembly of
complexes II and III.Table 1
Morphometric analysis of lymphoblast mitochondria by transmission electron microscopy.
Cell type Mitochondria Mitochondrial
surface density
Mitochondrial cross-section
(number per cell)
Percentage in the
cytoplasm
Percentage in
whole cells
Control 037 12 ± 3 8.1 ± 0.8 5.4 ± 0.9
Control 015-2 13 ± 3.5 8.0 ± 1.2 5.3 ± 0.7
Patient 105-3 26 ± 5⁎ 15.1 ± 2.4⁎ 10.1 ± 1.9⁎
Patient 105-2 24 ± 4.9⁎ 14.9 ± 2.5⁎ 9.8 ± 1.7⁎
⁎ Asterisks indicate a signiﬁcant difference between control DB037 and
patient-derived lymphoblasts DB105-3 (p b 0.05).RC complexes I, III and IV are organized into functional super-
complexes (I + III2 + IVn) [35]. We therefore investigated whether the
supermolecular organization of the RCwas affected inmutant cells. Mito-
chondrial samples obtained after two-step digitonin solubilization were
analyzed by BN-PAGE (Fig. 4B). Supercomplexes I + III2 + IVn were
best resolved with 0.16% DG, and were present in smaller amounts in
BTHS cells (54% of control).
Western blotting of SDS-PAGE gels of total cell lysates showed
lower steady-state levels of the 30 kDa subunit of complex I and of
cytochrome c oxidase subunit I (COXI) (Fig. 4C) in the mutant cells
than in the WT cells, consistent with the observed lower level of the
assembly of complexes I and IV.
3.5. OPA-1 status is not affected by TAZ gene defects
It has recently been suggested that OPA-1 controls cytochrome c
mobilization by forming local oligomers at crista junctions [36,37].
The stability of OPA-1 complexes may therefore be affected by the
CL environment. Mitochondria isolated from WT (DB037) and patient-
derived lymphoblasts (DB105-3) contained similar amounts of OPA-1
oligomers (Fig. 5). OPA-1 complex disassembly and a loss of cytochrome
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1199F. Gonzalvez et al. / Biochimica et Biophysica Acta 1832 (2013) 1194–1206cwere observed in DB037 cells treatedwith anti-Fas antibody (Fig. 5). By
contrast, no disruption of OPA-1 oligomers or cell death was observed in
lymphoblasts frompatients (Fig. 5). These observations suggest that BTHS
cellsmaymaintain OPA-1 complexes, possibly accounting for their capac-
ity to resist apoptosis. The stability of the OPA-1 complexes did not seem
to be affected by the changes in CL structure or the amount of CL observed
in the mutant (Fig. 2).
3.6. Bioenergetic state of BTHS and control lymphoblasts
We investigated whether the decrease in the amount of RC super-
complexes affected mitochondrial function and oxidative phosphoryla-
tion (OXPHOS), by investigating ATP synthesis and mitochondrial
respiration. No difference in ATP synthesis or mitochondrial respiration
was found betweenmutant andWT cells when the rateswere expressed
permgof protein (Table 2). Citrate synthase, an enzymeof themitochon-
drial matrix used as amarker of themitochondrial content, was found to
be signiﬁcantly increased in BTHS cells (Table 2). These results suggest
that BTHS cells had a greater mitochondrial content than control cells.
HPLC determinations on cell lysates showed that ATP/ADP ratio was
slightly lower in BTHS cells than in control cells (Fig. 6A). [AMP] is pro-
portional to the square of [ADP] divided by [ATP] (assuming close equi-
librium with adenylate kinase in most cells). Thus, if the absolute ATP
and ADP (Fig. 6A) levels are taken into account, together with [AMP],
[AMP] is clearly higher in BTHS cells than in control cells (Fig. 6B). Thisﬁnding is of particular importance, because an increase in AMP/ATP
ratio (from 0.078 in control to 0.103 in patient-derived cells) might
lead to the activation of AMP kinase, a major regulator of mitochondrial
biogenesis via the PGC1-alpha pathway, accounting for the observed in-
crease in mitochondrial mass. Furthermore, the NADH content of BTHS
lymphoblasts was higher than that of controls (Fig. 6C), suggesting that
this compound is not readily oxidized by the RC in the mitochondria of
these cells, most likely because of the deﬁcit in complex I.
3.7. Flow cytometry analysis of the early events of apoptosis in control
and BTHS lymphoblasts
We investigated LETD cleavage in control cells and cells frompatients,
in the presence (αCD95) and absence of apoptotic stimuli. The triggering
of apoptosis in control lymphoblasts led to the activation of caspase-8 and
cleavage of the LETD substrate (Fig. 7A). No such cleavage activitywas ob-
served when the same experiment was carried out with lymphoblasts
from patients (Fig. 7A).
The collapse of mitochondrial membrane potential (ΔΨm) is one of
the ﬁrst changes to occur in apoptosis [6,7]. We therefore investigated
the temporal relationship between the loss of ΔΨm and NAD(P)H oxi-
dation. Control cells and BTHS cells were labeled with TMRM, to obtain
information about ΔΨm changes (Fig. 7B). The treatment of cells with
αCD95 for 24 h decreased ΔΨm in a signiﬁcant proportion (65%) of
control cells (Fig. 7B). Apoptosis was almost totally inhibited in BTHS
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pare the lower right and lower left panels).
AsΔΨmdissipation is associatedwithNAD(P)H oxidation,we inves-
tigated the NAD(P)H status of both control and BTHS lymphoblasts. The
ﬂuorescence of reduced pyridine nucleotides (NADH and NADPH) ac-
counts for most of the autoﬂuorescence of cells induced by illumination
with near-UV light, and this autoﬂuorescence is generated almost exclu-
sively by the mitochondria. Oxidized pyridine nucleotides (NAD+ and
NADP+) are not ﬂuorescent. Changes in autoﬂuorescence therefore
reﬂect changes in the redox state of pyridine nucleotides. The absence
of a signiﬁcant difference in pyrimidine nucleotide oxidation ([NAD(P)
H]) between control and BTHS lymphoblasts and the data for NADH
determination demonstrated that NADH levels were higher in cells
from patients (Fig. 7C). We also monitored the oxidation of pyridine
nucleotides early in apoptosis, by analyzing control and BTHS lympho-
blasts incubated with and without αCD95 for 24 h. In most control
cells, NAD(P)H-dependent autoﬂuorescencewas decreased by treatment
for 24 h with αCD95 (Fig. 7C). However, this was not the case in cells
derived from patients, in which all these phenomena were inhibited.3.8. Other cell death characteristics abolished in BTHS lymphoblasts
Multiparameter analyses (Fig. 7) showed that most cells (77%) were
depleted ofNAD(P)Hwell before any increase in the generation of super-
oxide anions could be detected by hydroethidine (HE) staining (only
observed in 60% of cells; Table 3b). Caspase-3 activity was associated
with control cell apoptosis (Table 3a), but was abolished in cells from
the patient. Similarly, intracellular pH, as determined with the ﬂuores-
cent pH indicator SNARF-1AM, decreased in most control cells after
stimulation with aCD95 (Table 3a), but no change was recorded in cells
from patients, even after treatment with αCD95. We also investigated
intracellular K+ content (Table 3a) and the level of phosphatidyl serine
residue exposure at the plasma membrane, by annexin-V FITC staining
(Table 3a). The data obtained conﬁrmed that control lymphoblasts
underwent a normal apoptotic process, with the late occurrence of K+efﬂux and PS exposure, whereas BTHS cells were not affected by Fas
(αCD95).
Careful examination of the control and BTHS lymphoblasts might
reveal more subtle changes, even if apoptosis is undetectable in BTHS
cells. Following HE staining, basal levels of superoxide anion production
were reproducibly higher in BTHS cells (mean ﬂuorescence: 16 ±
0.9 AU; Table 3b, patient 105-3) than in control cells (mean ﬂuores-
cence: 8.4 ± 1.2 AU; Table 3b, control DB037).
3.9. Efﬁcacy of tBid and caspase-8 binding to isolated mitochondria from
control and BTHS lypmphoblasts
Apoptosis thus appears to be blocked at the mitochondrial level, at a
point before any decrease in mitochondrial membrane potential can be
measured or any change linked to the activation of apoptosis through
caspase-8, such as NAD(P)H reduction or caspase-3 activity, can be
detected. Before assessing caspase-8 binding and activity at the mito-
chondrial membrane, we evaluated the electropermeabilization by tBid
in control and BTHS lymphoblasts (Fig. 8). The introduction of tBid-FITC,
by electroloading, into control or BTHS lymphoblasts resulted in similar
staining patterns (Fig. 8A).Moreover, tBid induced apoptosis and necrosis
in both control and BTHS cells (Fig. 8B and C). An analysis of the effect of
introducing tBid into control (Fig. 8B) and BTHS (Fig. 8C) lymphoblasts
revealed that the BTHS lymphoblastsweremore sensitive to cell death in-
duction (Fig. 8C). The decrease in mitochondrial membrane potential af-
fected 70% of BTHS cells after 2 h, but only 40% of control lymphoblasts.
BTHS cells were also more sensitive to both apoptosis and necrosis
(≥80% of the lymphoblasts being affected at 4 h, whereas ≥60% of the
control cells died). There was also a marked shift from an apoptotic
phenotype to a necrotic phenotype in BTHS cells, during longer periods
of incubation with exogenous tBid (Fig. 8C).
Caspase activation often involves the formation of triggering com-
plexes or an activation platform.Many such complexes have been iden-
tiﬁed in the vicinity of the plasma membrane: the DSC for caspases-8
and -10 [38], the apoptosome for caspase-9 [39] and, more recently,
for caspase-8 [15], which seems to be inserted into the mitochondrial
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1201F. Gonzalvez et al. / Biochimica et Biophysica Acta 1832 (2013) 1194–1206membrane in its active form. We therefore investigated the selectivity
of the interaction between active caspase-8 and isolated mitochondria
from control and BTHS lymphoblasts (Table 4). Active caspase-8 was
clearly detected to be bound to themitochondrial membrane of control
lymphoblasts, but not to themitochondrialmembrane of BTHS lympho-
blasts. This binding appeared to be speciﬁc, because the ﬂuorescence
associated with isolated control mitochondria was abolished by addi-
tion of the pan-caspase inhibitor Bod-D-fmk or Z-IETD-fmk, which is
more selective for caspase-8.4. Discussion
4.1. There are fewer respiratory complexes, but higher levels of respiration
in BTHS cells
The two ATP-regenerating systemswithin cells adapt to the needs of
the cell. These two systems are the phosphorylation of ADP, using the
high-energy intermediates generated in the glycolytic pathway, and
oxidative phosphorylation in mitochondria, which involves the proton
motive force. These two processes must be coordinated and the total
ATP turnover of the cells must closelymatch actual requirements during
growth and differentiation, and the activation and performance of vari-
ous cellular functions. The free energy, ΔG, of ATP hydrolysis depends
principally on the ATP/ADP ratio. In general, with high energy turnover,
this ratio remains remarkably stable. For example, in heart muscle, it is
practically independent of workload and, thus, of ATP turnover [40].
Most of the cell's ATP is generated bymitochondrial oxidative phosphor-
ylation. The mitochondrial respiratory chain comprises a number of
DB 037 
DB 105-3 
AMP
0
10
20
30
40
0
1
2
3
4
ATP ADP
B
n
m
o
le
 /m
g 
pr
ot
ei
n
ATP/ADP AMP/ATP
DB 037 
DB 105-3 
Control cells Patient cells
NADH
NAD(P)H
Total
100
0
50
Pe
rc
e
n
t (%
)   
C
μm
o
le
 /m
g 
pr
ot
ei
n
A
Fig. 6. AMP/ADP/ATP content and pyrimidine nucleotide determination in control and
BTHS lymphoblasts. (A) Determination of the ADP and ATP contents of control lympho-
blasts (DB037) and of Barth syndrome patient-derived lymphoblasts (DB105-3). (B)
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Table 2
Respiratory chain analysis measured on intact cells. ATP synthesis activities, oxygen
consumption in the absence (coupled respiration) or presence (uncoupled respiration)
of FCCP and citrate synthase activity (CS). The values shown are means of at least three
independent measurements expressed in nmol/min/mg protein. Statistically signiﬁ-
cant differences between control (control 037) and BTHS patient-derived lymphoblasts
(patient 105-3) are indicated: *** = p b 0.0005, ** = p b 0.005, * = p b 0.05.
Activities
nmol/min/mg
ATP synthesis Coupled
respiration
Uncoupled
respiration
Citrate
synthase (CS)
Control 015 22.7 ± 1.1 7.5 ± 0.6 17.8 ± 0.8 162.3 ± 21.8
Patient 105-3 21.8 ± 1.1 7.1 ± 0.9 17.9 ± 2.7 263.2 ± 9.0***
ATP/CS Coupled/CS Uncoupled/CS
Control 015 0.14 ± 0.007 0.05 ± 0.004 0.11 ± 0.005
Patient 105-3 0.09 ± 0.005** 0.03 ± 0.004* 0.08 ± 0.011*
1202 F. Gonzalvez et al. / Biochimica et Biophysica Acta 1832 (2013) 1194–1206membrane-bound enzyme complexes, which transfer electrons from
NADH to oxygen, ultimately producing water and generating a proton
gradient across the inner mitochondrial membrane. Electrons from
NADH are initially transferred, via complex I (NADH:ubiquinone oxido-
reductase) and ubiquinone, to complex III (ubiquinol: cytochrome c
oxidoreductase). They then pass through the peripheral electron carrier
cytochrome c and complex IV (cytochrome c oxidase) to the terminal
acceptor, molecular oxygen. The electrochemical proton gradient gen-
erated is used by complex V (FOF1-ATP synthase) to produce ATP. The
respiratory chain complexes may be organized into multienzyme as-
semblies, known as supercomplexes. Such a supercomplex, consisting
of complex I, dimeric complex III, and a variable number of complex
IV units, has been visualized as a 3D map generated by random conical
tilt electronmicroscopy analysis [41]. The ubiquinone and cytochrome c
binding sites of each complex can be seen within the supercomplex,
located close to the site of binding to the next complex in the respiratory
chain. These ﬁndings provide structural evidence for direct substrate
channeling in supercomplex assembly, with short diffusion distances
for mobile electron carriers.
A destabilization of respiratory chain supercomplexes, accompanied
by a decrease in the amounts of individual complexes I, IV and V, was
observed in BTHS cells (Fig. 4). These results conﬁrm previous ﬁndings
for Barth syndrome cells [42] and are consistent with the hypothesis
that higher levels of electron transfer complex organization into
supercomplexes are dependent on CL. The decreased levels of complex
V (resolvedwith detergent lauryl maltoside, Fig. 4A panel 2) is interest-
ing, since this complex is not part of the supercomplex. The decrease
suggests that cardiolipin is required not only for the association/stabiliza-
tion of the complexes into supercomplexes but also for themodulation of
the amount of individual respiratory chain complexes.
Mitochondria from patients with Barth syndrome have a lower CL
content than control cells and also display changes in acyl chain composi-
tion (Fig. 2). Supercomplex destabilizationwould be expected to result in
electron transport defects [35]. Interestingly, isolated mitochondria from
patient's cells, display lower rates of coupled respiration but unchanged
uncoupled respiration as compared to mitochondria from cells from
normal individuals (Fig. 3). This indicates that the altered CL content
(Fig. 2) and the decreased amount of respiratory complexes and super-
complexes (Fig. 4) are only limiting for the biologically relevant coupled
respiration. BTHS cells show changes in mitochondrial structure (Fig. 1)
(also described by Acehan et al. [43]), in cardiolipin composition
(Fig. 2), and in the respiratory properties of isolated mitochondria
(Fig. 3), but unchanged respiration rates (Table 2) and similar ATP/ADP
ratios (Fig. 6). Thus, despite the problems caused by lower levels of CL
and fatty acid chain modiﬁcations, BTHS lymphoblasts can, nonetheless,
fulﬁll their energy demand by a compensatory increase in mitochondrial
mass, as shown by electron microscopy (Fig. 1 and Table 1) and citrate
synthase activity (Table 2).4.2. OPA-1 oligomer formation is not affected by the change in CL structure
in BTHS cells
OPA-1 status did not seem to be affected in BTHS cells (Fig. 5), despite
expectations of a destabilization of OPA-1 complexes due to the changes
in mitochondrial morphology observed on electron microscopy. OPA-1
oligomer formation and GTP hydrolysis have been shown to be increased
by cardiolipin [17]. We anticipated a possible destabilization of OPA-1
complexes due to the smaller amount of CL present and themodiﬁcations
to the acyl chains of CL molecules, but we found no difference in OPA-1
complex formation between control and BTHS lymphoblasts (Fig. 5).
This suggests that CL acyl chains, which are clearly more saturated in
patient-derived cells, are not involved in OPA-1 complex formation.
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Fig. 7. Flow cytometry analysis of early apoptotic events in control and BTHS lymphoblasts. Lymphoblasts were incubated for 24 h with or without 0.5 mg/ml Fas antibody, and the
following were assessed: (A) caspase-8 activity, as measured by LETD cleavage activity. (B) Mitochondrial membrane potential assessed on the basis of TMRM and cellular viability
(TO-PRO-3) and (C) NAD(P)H ﬂuorescence.
1203F. Gonzalvez et al. / Biochimica et Biophysica Acta 1832 (2013) 1194–1206OPA-1 proteolysis during apoptosis has been linked to a decrease in
ΔΨm and mitochondrial fusion, leading to mitochondrial ﬁssion and
dysfunction [16,44–46]. None of these phenomena were observed in
BTHS cells, in which no OPA-1 complex modiﬁcation occurred. We
therefore, suggest that the fundamental interactions involved in
OPA-1 stability mediated by the cardiolipin are not affected in BTHS
cells and that these interactions, therefore, remained unchanged in
patient-derived cells, regardless of the changes in the mitochondrial
compartment. This allows us to speculate on the nature of OPA-1 to
cardiolipin relationship which could potentially or not be mediated by
the polar head of the cardiolipin (which is unaffected) rather than by
the acyl chains (which are more saturated).4.3. Apoptotic platform formation cannot occur in BTHS cells
Control cells underwent prototypic apoptosis, including caspase-8
activation, a decrease in ΔΨm associated with NAD(P)H oxidation
and superoxide anion production followed by caspase-3 activation.
In addition, all the expected late events were observed: K+ efﬂux,
pH changes and aberrant phosphatidyl serine residue exposure at
the surface of the plasma membrane (Fig. 7, Table 1). However, all
these apoptosis-associated events were abolished in BTHS cells,
which were unable to undergo apoptosis via the mitochondrial path-
way. Even so, it was important to determine whether some apoptotic
pathway unlinked to caspase activation was preserved in these cells
Table 4
Caspase-8 binding to mitochondria from control and BTHS lymphoblasts. After lympho-
blasts were incubated for 8 h with or without 0.5 mg/ml Fas antibody, mitochondria
where extracted and puriﬁed. FAM-LETD-fmk was incubated with isolated mitochondria
for 1 h at 37 °C, and the mitochondria were then washed twice in respiratory buffer and
analyzed by ﬂow cytometry. As a control, mitochondria were ﬁrst incubated for 15 min
at 37 °C with the caspase-8 inhibitor Z-IETD-fmk (50 μM) or the pan-caspase inhibitor
Q-VD-OPH (10 μM, which has the advantage of not affecting cathepsin and calpain activ-
ities) and then incubated with FAM-LETD-fmk, which binds to the catalytic site of
caspase-8 if this enzyme is present at the mitochondrial surface. The data are expressed
as mean ﬂuorescence values (mean F, arbitrary units, a.u.) for a cell population subjected
to the treatment concerned. The control values correspond to autoﬂuorescence.
Conditions Control mitochondria
(mean F, a.u.)
BTHS mitochondria
(mean F, a.u.)
Control 8.9 ± 1.1 8.7 ± 1.0
FAM-LETD-fmk 87.5 ± 1.9 13.9 ± 2.0
FAM-LETD-fmk + Z-IETD-fmk 12.7 ± 1.8 9.8 ± 1.8
FAM-LETD-fmk + Q-VD-OPH 12.9 ± 2.0 11.2 ± 1.9
Table 3
Flow cytometry analysis of apoptosis-associated events occurring in control and BTHS
lymphoblasts. Lymphoblasts were incubated for 24 h with or without 0.5 mg/ml Fas
antibody, and the following were assessed: (a) caspase-3 cleavage activity, measured
as DEVD cleavage activity, phosphatidyl serine residue exposure at the outer surface of
the plasma membrane (annexin V-FITC binding in the presence of calcium), potassium
efﬂux, evaluated by determining monochlorobimane ﬂuorescence and pH changes
based on SNARF-1AM cleavage and ﬂuorescence. The data are expressed as a percentage
of cells (%). (b) Reactive oxygen species (superoxide anion) production, detected by HE
cleavage in the mean ﬂuorescence channel (F on 256 channel)a is given, together with
the percentage (%) of viable cells (TO-PRO-3-negative cells)b.
Conditions
(% cells)
Control
037
Control
037 + Fas
Patient
105-3
Patient
105-3 + Fas
a
Caspase-3+ 6 ± 3 62 ± 3 5 ± 3 15 ± 3
Annexin V+ 12 ± 2 65 ± 3 9 ± 2 12 ± 2
K+ low 6 ± 2 51 ± 4 4 ± 3 9 ± 4
pH (intracellular) 7.4 ± 0.1 6.9 ± 0.1 7.4 ± 0.1 7.4 ± 0.1
b
HE+ (% cells) 3 ± 2 60 ± 3 9 ± 2 14 ± 2
HE (mean Fa
of viable cells)
8.4 ± 1.2a
(97%)b
10.1 ± 1.2a
(40%)b
16 ± 0.9a
(81%)b
18 ± 0.9a
(76%)b
The bold emphasis the value determined for the patient.
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capase-8.
When present (i.e., introduced intracellularly by square pulsed
electropermeabilization), tBid induced a higher rate of apoptosis in
BTHS cells than in controls (Fig. 8A), undoubtedly due to the higher
MLCL content of these cells (Fig. 2). Consistent with this observation,
tBid has been reported to have a high afﬁnity forMLCL [47]. These results
indicate that apoptosis in BTHS cells is blocked at the level of tBid
production (resulting in an absence of the activation platform usually
formed by caspase-8/Bid and mature CL), suggesting that this process
may be strictly related to caspase-8 activity at the mitochondrial plat-
form [15]. Active caspase-8 binding tomitochondria seemed to be affect-
ed in BTHS cells (Table 4), as we detected no binding of FAM-LETD-fmkElectroloadin
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Fig. 8. Electropermeabilization by tBid in control and BTHS lymphoblasts, demonstratin
electroloaded with tBid-FITC (similar efﬁciency for the two cell lines). (B) Measurement
electroloading in control lymphoblasts (DB037). (C) Measurement of the decrease in mitoc
lymphoblasts (DB105-3).to BTHS mitochondria, whereas the control cells displayed FAM-
LETD-fmk ﬂuorescence associated with the binding of active caspase-8
to mitochondria. Overall, these results conﬁrm previous ﬁndings that a
caspase-8/Bid/cardiolipin platform is generated atmitochondrial contact
sites but that this platform cannot form in the presenceofmodiﬁed CL, as
in BTHS cells [15]. It has also been proposed that the absence of platform
formation simply reﬂects the reduced amount of CL in Barth syndrome.
This is inconsistent with our observation that the low level of CL in
CLS1 knockdown HeLa cells does not lead to an inhibition of apoptosis
but actually accelerates it (the platform is formed and tBid is produced,
and it is able to interact efﬁciently with the remaining CL) towards
secondary necrosis [14].
4.4. BTHS cells may be more sensitive to stress
The cardiolipin metabolism defect associated with Barth syn-
drome manifests as CL depletion, MLCL accumulation and CL species
diversiﬁcation, resulting in the generation of CLmoleculeswith differentg of  tBid-FITC
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g their ability to undergo tBid-mediated cell death. (A) FITC-ﬂuorescence of cells
of the decrease in mitochondrial membrane potential and cell death induced by tBid
hondrial membrane potential and cell death induced by tBid electroloading in patient
1205F. Gonzalvez et al. / Biochimica et Biophysica Acta 1832 (2013) 1194–1206fatty acyl compositions [3,41,48,49]. It remains unclear whether and
how abnormal CL homeostasis actually plays a role in the pathogenesis
of Barth syndrome.
Our ﬁndings highlight major effects of CL depletion and changes to
acyl chain composition in the remaining CL on the structure and functions
of mitochondria in the lymphoblasts of BTHS patients. These alterations
are almost entirely compensated at the cellular level, in terms of bioener-
getics, by an increase inmitochondrial mass. They are, therefore, unlikely
to have a profound impact on cell fate in the short term. However, cells
from patients may be more sensitive to stress and to long-term micro-
destabilization, because the only remarkable characteristic of these cells
observed here was a higher basal level of superoxide anion production
(Table 3). This characteristic has been previously described in the yeast
taz1Δmutant,which exhibits an increased protein carbonylation, an indi-
cator of reactive oxygen species (ROS) [50]. These results suggest that
yeast cell mutant models might be very useful to decipher some path-
ways which might have been conserved from yeast to mammals [51].
Thus, although conditions differ markedly between tissues, affected tis-
sues may be more sensitive to the destabilization of their environment
and to stress.
Mitochondrial dysfunction and the inhibition of proapoptotic signal-
ing via mitochondria may cooperate in disease pathogenesis. Effective-
ly, the extrinsic, or death receptor pathway integrates apoptotic signals
via caspase-8. The non-apoptotic functions of caspase-8 include an
essential role in hematopoiesis and lymphocyte clonal expansion, and
the tempering of autophagy in T cells. The catalysis-competent form
of caspase-8 is required for rapid T-cell proliferation in response to
TCR activation, but caspase-8 processing is required only to promote ap-
optosis [52]. The pathologic effects of the accumulation of uncleaved
caspase-8 are unknown, and will present a challenge in the develop-
ment of new treatments. Furthermore, questions remain aboutwhether
the lack of activation of this speciﬁc apoptotic pathway, which is
required for normal cell function, is of importance in Barth syndrome
lymphocytes and whether it may lead to an increase in inﬂammation,
because other cell death-inducing pathways not requiring caspase-8
activation are conserved.
Questions also remain concerning similarities to Barth syndrome
neutrophils. The mitochondria of neutrophils from patients with
Barth syndrome, despite their almost exclusive role in glycolysis,
have several impairments in common with lymphoblast mitochon-
dria [1]. The respiratory chain is disrupted in neutrophils: electrons
are received by complex III, but seem to be transferred rarely, if at
all, to complex IV and then to molecular oxygen to generate H2O. In-
stead, electrons may be transferred directly to oxygen in complex III,
increasing the production of reactive oxygen species (ROS), which
may have potentially harmful effects or may, alternatively, form
part of as yet undiscovered signaling cascades in neutrophils [1].
An evaluation of the potential value of antioxidant treatments
would be useful, particularly given the high levels of superoxide pro-
duction by Barth syndrome lymphocytes (Table 3) and the clinical
trials currently underway concerning the use of coenzyme Q10 in
other mitochondriopathies (NIH, USA, Phase III trials of Coenzyme
Q10 for mitochondrial diseases).
Future therapeutic interventions might also be based on the restora-
tion of CL levels and fatty acid composition. One promising possibility
concerns inhibition of the Ca2+-dependent iPLA2-Via. The mature acyl
chain composition of CL is determined by a remodeling process that is de-
pendent on tafazzin. Tafazzin catalyzes phospholipid–lysophospholipid
transacylation, a process involving both the deacylation of CL and the
reacylation of MLCL. Unlike the CoA-dependent deacylation–reacylation
cycle, this process does not require acylCoA, instead it involves the direct
transfer of a fatty acid chain from a phospholipid to a lysophospholipid,
without the need for phospholipase A2 and without the generation of
free fatty acid [53]. Nevertheless, a Ca2+-dependent phospholipase A2
(PLA2-VIA) does play a major role in this process, because this enzyme,
which is not required for cardiolipin remodeling [53], seems to have acentral function in the absence of taffazin or in situations inwhich tafazzin
is nonfunctional [54], leading to CL depletion and the accumulation of
MLCL. The Ca2+-independent iPLA2-VIA has been implicated in diverse
biological processes, including phospholipid remodeling, arachidonic
acid release, apoptosis and store-operated Ca2+ entry [55]. In addition,
iPLA2-VIA knockout mice develop age-dependent neurological impair-
ment [56,57] and mutations in the iPLA2-VI. A gene has been identiﬁed
in patients with infantile neuroaxonal dystrophy and neurodegeneration
with iron accumulation in the brain [58,59]. It is therefore tempting to
focus on the study and development of speciﬁc inhibitors of PLA2-VIA
and their speciﬁc targeting to tissues. The recent description of a mouse
model of Barth syndromewill also greatly facilitate work in this area [54].
4.5. Summary
In summary, our ﬁndings provide new insight into the pathogenesis
of BTHS, by highlighting the role played by CL-containing microdomains
atmitochondrial contact sites, as tafazzinmutation lead to an impairment
of tafazzin function and the production of smaller amounts of CL with
modiﬁed acyl chains and the accumulation of monolysocardiolipin,
resulting in the impairment of the pro-apoptotic signal. This highlights
the importance of the non apoptotic functions of caspase-8 and the con-
tribution of mitochondrial bioenergetic failure even in the presence of
compensation at the cellular level. One major question for future studies
concerns possible changes in autophagic ﬂuxes, because the inhibition of
apoptosis may trigger an increase in autophagy, the elimination of un-
wanted mitochondria and higher superoxide levels.
Acknowledgements
We thank Jesus Ayala-Sanmartin for assistance with liposome
preparation. We also thank David Brooks for providing us with the
BTHS cell lines (Division of Medical Genetics, University of Pennsylvania,
Philadelphia, PA 19104). P.X. Petit was supported by the Centre National
de la Recherche Scientiﬁque (CNRS) and the Association Française contre
les Myopathies (AFM) Grants, 11557, 13313 and 15137. F. Gonzalvez, O.
Jalmar, L. Arnauré, N. Talleux, M. D'Aurelio, P. Bellenger, E. Gottlieb and
P.X. Petit designed the experiments. P.X. Petit, M. D'Aurelio, P. Bellenger,
I.M. Møller, G. Manfredi, and F. Gonzalvezwrote themanuscript.We also
thank L.P. Aggerbeck for participation in the manuscript editing. The
authors have no conﬂicting scientiﬁc or ﬁnancial interests.
References
[1] T.W. Kuijpers, N.A. Maianski, A.T. Tool, K. Becker, B. Plecko, F. Valianpour, R.J.
Wanders, R. Pereira, J. Van Hove, A.J. Verhoeven, D. Roos, F. Baas, P.G. Barth, Neutro-
phils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis,
Blood 103 (2004) 3915–3923.
[2] P.G. Barth, F. Valianpour, V.M. Bowen, J. Lam, M. Duran, F.M. Vaz, R.J. Wanders,
X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update,
Am. J. Med. Genet. A 126 (2004) 349–354.
[3] M. Schlame, M. Ren, Barth syndrome, a human disorder of cardiolipin metabolism,
FEBS Lett. 580 (2006) 5450–5455.
[4] S. Bione, P. D'Adamo, E. Maestrini, A.K. Gedeon, P.A. Bolhuis, D. Toniolo, A novel
X-linked gene, G4.5. is responsible for Barth syndrome, Nat. Genet. 12 (1996)
385–389.
[5] P. Vreken, F. Valianpour, L.G. Nijtmans, L.A. Grivell, B. Plecko, R.J. Wanders, P.G.
Barth, Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syn-
drome, Biochem. Biophys. Res. Commun. 279 (2000) 378–382.
[6] F.M. Vaz, R.H. Houtkooper, F. Valianpour, P.G. Barth, R.J. Wanders, Only one splice
variant of the human TAZ gene encodes a functional protein with a role in
cardiolipin metabolism, J. Biol. Chem. 278 (2003) 43089–43094, (Epub 42003
Aug 43020).
[7] Y. Xu, R.I. Kelley, T.J. Blanck, M. Schlame, Remodeling of cardiolipin by phospho-
lipid transacylation, J. Biol. Chem. 278 (2003) 51380–51385.
[8] Y. Xu, A. Malhotra, M. Ren, M. Schlame, The enzymatic function of tafazzin, J. Biol.
Chem. 281 (2006) 39217–39224.
[9] M. Schlame, D. Rua, M.L. Greenberg, The biosynthesis and functional role of
cardiolipin, Prog. Lipid Res. 39 (2000) 257–288.
[10] D. Ardail, J.P. Privat,M. Egret-Charlier, C. Levrat, F. Lerme, P. Louisot,Mitochondrial con-
tact sites. Lipid composition and dynamics, J. Biol. Chem. 265 (1990) 18797–18802.
[11] R.H. Houtkooper, F.M. Vaz, Cardiolipin, the heart of mitochondrial metabolism,
Cell. Mol. Life Sci. 65 (2008) 2493–2506.
1206 F. Gonzalvez et al. / Biochimica et Biophysica Acta 1832 (2013) 1194–1206[12] M. Zhang, E. Mileykovskaya, W. Dowhan, Gluing the respiratory chain together:
cardiolipin is required for supercomplex formation in the inner mitochondrial
membrane, J. Biol. Chem. 2 (2002) 2.
[13] M. Schlame, M. Ren, The role of cardiolipin in the structural organization of mito-
chondrial membranes, Biochim. Biophys. Acta 1788 (2009) 2080–2083.
[14] S.Y. Choi, F. Gonzalvez, G.M. Jenkins, C. Slomianny, D. Chretien, D. Arnoult, P.X.
Petit, M.A. Frohman, Cardiolipin deﬁciency releases cytochrome c from the
inner mitochondrial membrane and accelerates stimuli-elicited apoptosis, Cell
Death Differ. 14 (2007) 597–606.
[15] F. Gonzalvez, Z.T. Schug, R.H. Houtkooper, E.D. Mackenzie, D.G. Brooks, R.J.
Wanders, P.X. Petit, F.M. Vaz, E. Gottlieb, Cardiolipin provides an essential activat-
ing platform for caspase-8 on mitochondria, J. Cell Biol. 183 (2008) 681–696.
[16] R.M. DeVay, L. Dominguez-Ramirez, L.L. Lackner, S. Hoppins, H. Stahlberg, J.
Nunnari, Coassembly of Mgm1 isoforms requires cardiolipin and mediates mito-
chondrial inner membrane fusion, J. Cell Biol. 186 (2009) 793–803.
[17] T. Ban, J.A. Heymann, Z. Song, J.E. Hinshaw, D.C. Chan, OPA1 disease alleles causing
dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and
membrane tubulation, Hum. Mol. Genet. 19 (2010) 2113–2122.
[18] A.S. Rambold, J. Lippincott-Schwartz, Mechanisms of mitochondria and autophagy
crosstalk, Cell Cycle 10 (2011) 4032–4038.
[19] M. Schlame, D. Acehan, B. Berno, Y. Xu, S. Valvo, M. Ren, D.L. Stokes, R.M. Epand,
The physical state of lipid substrates provides transacylation speciﬁcity for
tafazzin, Nat. Chem. Biol. 8 (2012) 862–869.
[20] C. Kantari, H. Walczak, Caspase-8 and bid: caught in the act between death recep-
tors and mitochondria, Biochim. Biophys. Acta 1813 (2011) 558–563.
[21] Z.T. Schug, F. Gonzalvez, R.H. Houtkooper, F.M. Vaz, E. Gottlieb, BID is cleaved by
caspase-8 within a native complex on the mitochondrial membrane, Cell Death
Differ. 18 (2011) 538–548.
[22] Y. Xu, J.J. Sutachan, H. Plesken, R.I. Kelley, M. Schlame, Characterization of lym-
phoblast mitochondria from patients with Barth syndrome, Lab. Invest. 85
(2005) 823–830.
[23] J. Johnston, R.I. Kelley, A. Feigenbaum, G.F. Cox, G.S. Iyer, V.L. Funanage, R.
Proujansky, Mutation characterization and genotype–phenotype correlation in
Barth syndrome, Am. J. Hum. Genet. 61 (1997) 1053–1058.
[24] F. Valianpour, R.J. Wanders, H. Overmars, P. Vreken, A.H. Van Gennip, F. Baas, B.
Plecko, R. Santer, K. Becker, P.G. Barth, Cardiolipin deﬁciency in X-linked
cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a
study in cultured skin ﬁbroblasts, J. Pediatr. 141 (2002) 729–733.
[25] O. Seksek, N.H. Toulmé, F. Sureau, J. Bolard, SNARF-1 as an intracellular pH indicator
in lasermicrospectrometry, a critical assessment, J. Anal. Biochem. 193 (1991) 49–54.
[26] J.A. Thomas, R.N. Buschbaum, A. Zimniak, E. Racker, Intracellular pH measure-
ment in Ehrlich ascite tumor cells utilizing spectroscopic probes generated in
situ, Biochemistry 18 (1979) 2210–2218.
[27] B. Gabriel, F. Sureau, M. Casselyn, J. Teissie, P.X. Petit, Retroactive pathway involving
mitochondria in electroloaded cytochrome c-induced apoptosis. Protective properties
of Bcl-2 and Bcl-XL, Exp. Cell Res. 289 (2003) 195–210.
[28] M.C. Gendron, N. Schrantz, D. Metivier, G. Kroemer, Z. Maciorowska, F. Sureau,
S. Koester, P.X. Petit, Oxidation of pyridine nucleotides during Fas- and ceramide-
induced apoptosis in Jurkat cells: correlation with changes in mitochondria, gluta-
thione depletion, intracellular acidiﬁcation and caspase 3 activation, Biochem. J.
353 (2001) 357–367.
[29] T. Bourgeron, D. Chretien, A. Rötig, A. Munnich, P. Rustin, Isolation and character-
ization of mitochondria from human B lymphoblastoid cell lines, Biochem.
Biophys. Res. Commun. 186 (1992) 16–23.
[30] C. Vives-Bauza, L. Yang, G. Manfredi, Assay ofmitochondrial ATP synthesis in animal
cells and tissues, Methods Cell Biol. 80 (2007) 155–171.
[31] M. D'Aurelio, F. Pallotti, A. Barrientos, C.D. Gajewski, J.Q. Kwong, C. Bruno, M.F.
Beal, G. Manfredi, In vivo regulation of oxidative phosphorylation in cells harboring
a stop-codon mutation in mitochondrial DNA-encoded cytochrome c oxidase
subunit I, J. Biol. Chem. 276 (2001) 46925–46932.
[32] I.A. Trounce, Y.L. Kim, A.S. Jun, D.C. Wallace, Assessment of mitochondrial oxidative
phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial
cell lines, Methods Enzymol. 264 (1996) 484–509.
[33] A. Olichon, L.J. Emorine, E. Descoins, L. Pelloquin, L. Brichese, N. Gas, E. Guillou, C.
Delettre, A. Valette, C.P. Hamel, B. Ducommun, G. Lenaers, P. Belenguer, The
human dynamin-related protein OPA1 is anchored to the mitochondrial inner
membrane facing the inter-membrane space, FEBS Lett. 523 (2002) 171–176.
[34] T. Landes, L.J. Emorine, D. Courilleau, M. Rojo, P. Belenguer, L. Arnaure-Pelloquin,
The BH3-only Bnip3 binds to the dynaminOpa1 to promotemitochondrial fragmen-
tation and apoptosis by distinct mechanisms, EMBO Rep. 11 (2010) 459–465.
[35] M. D'Aurelio, C.D. Gajewski, G. Lenaz, G. Manfredi, Respiratory chain super-
complexes set the threshold for respiration defects in human mtDNA mutant
cybrids, Hum. Mol. Genet. 15 (2006) 2157–2169.
[36] C. Frezza, S. Cipolat, O. Martins de Brito, M. Micaroni, G.V. Beznoussenko, T.
Rudka, D. Bartoli, R.S. Polishuck, N.N. Danial, B. De Strooper, L. Scorrano, OPA1controls apoptotic cristae remodeling independently from mitochondrial fusion,
Cell 126 (2006) 177–189.
[37] R. Yamaguchi, L. Lartigue, G. Perkins, R.T. Scott, A. Dixit, Y. Kushnareva, T. Kuwana,
M.H. Ellisman, D.D. Newmeyer, Opa1-mediated cristae opening is Bax/Bak and
BH3 dependent, required for apoptosis, and independent of Bak oligomerization,
Mol. Cell 31 (2008) 557–569.
[38] F.C. Kischkel, S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P.H. Krammer,
M.E. Peter, Cytotoxicity-dependent Apo-1 (FAs/CD95)-associated proteins form
a death-inducing signaling complex (DISC) with the receptor, EMBO J. 14
(1995) 5579–5588.
[39] H. Zou, Y. li, X. Liu, X. Wang, An APAF-1.cytochrome c multimeric complex is a
functional apoptososome that activates procaspase-9, J. Biol. Chem. 274 (1999)
11549–11556.
[40] J.S. Ingwall, R.G.Weiss, Is the failing heart energy starved?On using chemical energy
to support cardiac function, Circ. Res. 95 (2004) 135–145.
[41] E. Schafer, N.A. Dencher, J. Vonck, D.N. Parcej, Three-dimensional structure of the
respiratory chain supercomplex I1III2IV1 from bovine heart mitochondria, Bio-
chemistry 46 (2007) 12579–12585.
[42] M. McKenzie, M. Lazarou, D.R. Thorburn, M.T. Ryan, Mitochondrial respiratory
chain supercomplexes are destabilized in Barth Syndrome patients, J. Mol. Biol.
361 (2006) 462–469.
[43] D. Acehan, Y. Xu, D.L. Stokes, M. Schlame, Comparison of lymphoblast mitochondria
from normal subjects and patients with Barth syndrome using electron microscopic
tomography, Lab. Invest. 87 (2007) 40–48.
[44] S. Duvezin-Caubet, R. Jagasia, J. Wagener, S. Hofmann, A. Trifunovic, A. Hansson,
A. Chomyn,M.F. Bauer, G. Attardi, N.G. Larsson,W. Neupert, A.S. Reichert, Proteolytic
processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial
morphology, J. Biol. Chem. 281 (2006) 37972–37979.
[45] L. Griparic, T. Kanazawa, A.M. van der Bliek, Regulation of the mitochondrial
dynamin-like protein Opa1 by proteolytic cleavage, J. Cell Biol. 178 (2007)
757–764.
[46] Z. Song, H. Chen, M. Fiket, C. Alexander, D.C. Chan, OPA1 processing controls mito-
chondrial fusion and is regulated by mRNA splicing, membrane potential, and
Yme1L, J. Cell Biol. 178 (2007) 749–755.
[47] M.D. Esposti, I.M. Cristea, S.J. Gaskell, Y. Nakao, C. Dive, Proapoptotic bid binds to
monolysocardiolipin, a new molecular connection between mitochondrial mem-
branes and cell death, Cell Death Differ. 10 (2003) 1300–1309.
[48] A. Malhotra, I. Edelman-Novemsky, Y. Xu, H. Plesken, J. Ma, M. Schlame, M. Ren,
Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome,
Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 2337–2341.
[49] M.A. van Werkhoven, D.R. Thorburn, A.K. Gedeon, J.J. Pitt, Monolysocardiolipin in
cultured ﬁbroblasts is a sensitive and speciﬁc marker for Barth syndrome, J. Lipid
Res. 47 (2006) 2346–2351.
[50] S. Chen, Q. He, M.L. Greenberg, Loss of tafazzin in yeast leads to increased oxidative
stress during respiratory growth, Mol. Microbiol. 68 (2008) 1061–1072.
[51] Z. Gu, F. Valianpour, S. Chen, F.M. Vaz, G.A. Hakkaart, R.J. Wanders, M.L. Greenberg,
Aberrant cardiolipinmetabolism in the yeast taz1mutant: amodel for Barth syndrome,
Mol. Microbiol. 51 (2004) 149–158.
[52] S. Leverrier, G.S. Salvesen, C.M. Walsh, Enzymatically active single chain caspase-8
maintains T-cell survival during clonal expansion, Cell Death Differ. 18 (2011)
90–98.
[53] M. Schlame, Cardiolipin synthesis for the assembly of bacterial and mitochondrial
membranes, J. Lipid Res. 49 (2008) 1607–1620.
[54] M.S. Soustek, D.J. Falk, C.S. Mah, M.J. Toth, M. Schlame, A.S. Lewin, B.J. Byrne, Char-
acterization of a transgenic short hairpin RNA-induced murine model of tafazzin
deﬁciency, Hum. Gene Ther. 22 (2011) 865–871.
[55] R.H. Schaloske, E.A. Dennis, The phospholipase A2 superfamily and its group
numbering system, Biochim. Biophys. Acta 1761 (2006) 1246–1259.
[56] K. Shinzawa, H. Sumi, M. Ikawa, Y. Matsuoka, M. Okabe, S. Sakoda, Y. Tsujimoto,
Neuroaxonal dystrophy caused by group VIA phospholipase A2 deﬁciency in
mice: a model of human neurodegenerative disease, J. Neurosci. 28 (2008)
2212–2220.
[57] I. Malik, J. Turk, D.J. Mancuso, L. Montier, M. Wohltmann, D.F. Wozniak, R.E.
Schmidt, R.W. Gross, P.T. Kotzbauer, Disrupted membrane homeostasis and accu-
mulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal
dystrophy caused by PLA2G6 mutations, Am. J. Pathol. 172 (2008) 406–416.
[58] S. Khateeb, H. Flusser, R. Oﬁr, I. Shelef, G. Narkis, G. Vardi, Z. Shorer, R. Levy, A.
Galil, K. Elbedour, O.S. Birk, PLA2G6 mutation underlies infantile neuroaxonal
dystrophy, Am. J. Hum. Genet. 79 (2006) 942–948.
[59] N.V. Morgan, S.K. Westaway, J.E. Morton, A. Gregory, P. Gissen, S. Sonek, H.
Cangul, J. Coryell, N. Canham, N. Nardocci, G. Zorzi, S. Pasha, D. Rodriguez, I.
Desguerre, A. Mubaidin, E. Bertini, R.C. Trembath, A. Simonati, C. Schanen, C.A.
Johnson, B. Levinson, C.G. Woods, B. Wilmot, P. Kramer, J. Gitschier, E.R. Maher,
S.J. Hayﬂick, PLA2G6, encoding a phospholipase A2, ismutated in neurodegenerative
disorders with high brain iron, Nat. Genet. 38 (2006) 752–754.
